Abstract B51: A phase I dose‐escalation study of MGCD265 in patients with advanced malignancies (study 265‐102)
2006 ◽
Vol 24
(5)
◽
pp. 413-421
◽
2008 ◽
Vol 26
(4)
◽
pp. 347-354
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3030-3030
◽